**Core Concept**
Troponin-T and CPK-MB are cardiac biomarkers used to diagnose acute myocardial infarction (MI). Troponin-T is a more sensitive and specific marker for cardiac muscle damage, making it a preferable choice in many scenarios.

**Why the Correct Answer is Right**
Troponin-T is released into the bloodstream from damaged cardiac muscle cells, and its levels remain elevated for a longer period than CPK-MB. This allows for a more accurate diagnosis of MI, even in cases where the damage is not extensive. In contrast, CPK-MB is more specific to the heart but has a shorter half-life, making it less suitable for diagnosing MI in certain situations.

**Why Each Wrong Option is Incorrect**
**Option A:** In diagnosing reperfusion therapy after acute MI, CPK-MB is actually preferable to Troponin-T because it can help monitor the effectiveness of reperfusion therapy by rapidly declining after restoration of blood flow.
**Option B:** In diagnosing MI in patients with renal failure, Troponin-T is still preferable to CPK-MB because it is less affected by renal impairment and can provide a more accurate diagnosis.
**Option C:** In diagnosing MI in patients with skeletal muscle injury, Troponin-T is preferable to CPK-MB because it is more specific to cardiac muscle damage and can help differentiate between cardiac and skeletal muscle injury.

**Clinical Pearl / High-Yield Fact**
When using cardiac biomarkers to diagnose MI, it's essential to consider the patient's renal function, as elevated creatinine levels can affect the accuracy of CPK-MB measurements.

**Correct Answer: D.**